
浏览全部资源
扫码关注微信
400037 重庆,陆军军医大学(第三军医大学)第二附属医院眼科
[袁容娣, E-mail: yuanrongdi@126.comYUAN Rongdi, E-mail: yuanrongdi@126.com
收稿:2024-03-13,
修回:2024-04-30,
纸质出版:2024-09-30
移动端阅览
王玉雯, 李芙蓉, 袁容娣. Gpr124对高糖环境下视网膜微血管内皮细胞增殖、迁移和血管形成的调控作用[J]. 陆军军医大学学报, 2024,46(18):2101-2109.
Yuwen WANG, Furong LI, Rongdi YUAN. Regulatory effect of Gpr124 on proliferation, migration and angiogenesis of retinal microvascular endothelial cells under high-glucose condition[J]. Journal of Army Medical University, 2024, 46(18): 2101-2109.
王玉雯, 李芙蓉, 袁容娣. Gpr124对高糖环境下视网膜微血管内皮细胞增殖、迁移和血管形成的调控作用[J]. 陆军军医大学学报, 2024,46(18):2101-2109. DOI: 10.16016/j.2097-0927.202403058.
Yuwen WANG, Furong LI, Rongdi YUAN. Regulatory effect of Gpr124 on proliferation, migration and angiogenesis of retinal microvascular endothelial cells under high-glucose condition[J]. Journal of Army Medical University, 2024, 46(18): 2101-2109. DOI: 10.16016/j.2097-0927.202403058.
目的
2
研究高糖环境下人视网膜微血管内皮细胞(human retinal microvascular endothelial cell,HRMEC)中G蛋白偶联受体124(Gpr124)表达的变化,以及干扰Gpr124对HRMEC的调控作用。
方法
2
免疫荧光观察Gpr124在HRMEC中的表达;高糖刺激HRMEC,将细胞分为空白组和高糖组,CCK-8、EdU检测细胞活力与增殖情况;病毒抑制Gpr124表达后,将细胞分为空白对照组、高糖对照组、高糖+shRNA组以及高糖+Gpr124 shRNA组,划痕实验评估细胞迁移,基质凝胶评估细胞小管形成能力。Western blot检测Gpr124、VEGFA、MMP9和β-catenin相对蛋白表达水平。
结果
2
相较于空白组,HRMEC在高糖组中显示出显著提升的细胞活力和增殖细胞数(
P
<
0.01)。高糖环境下,Gpr124、VEGFA以及MMP9的表达水平也显著增加(
P
<
0.01)。同时,在各个时间点,高糖对照组的迁移面积以及体外血管形成面积和管径长度均显著高于空白对照组(
P
<
0.01)。然而,在敲低Gpr124的表达后,高糖+Gpr124 shRNA组的HRMEC在迁移和体外血管形成能力上相较于高糖+shRNA组有显著的降低(
P
<
0.01),并且高糖+Gpr124 shRNA组相比于高糖+shRNA组VEGFA、MMP9以及β-catenin蛋白表达减少(
P
<
0.01)。
结论
2
Gpr124能够调控高糖环境下HRMEC的增殖、迁移以及管形成能力,并且还可以抑制VEGFA和MMP9的过度表达,这一影响可能是通过调节Wnt/β-catenin经典通路来实现的。
Objective
2
To investigate the changes in G protein-coupled receptor 124 (Gpr124) expression in human retinal microvascular endothelial cells (HRMEC) under high-glucose condition and the regulatory effect of Gpr124 interference on HRMEC.
Methods
2
Immunofluorescence assay was used to observe the expression of Gpr124 in HRMEC. The cells were divided into a blank group and a high glucose group. CCK-8 assay and EdU cell proliferation assay were used to detect cell viability and proliferation
respectively. The Gpr124 expression was knocked down by transducting lentiviral virus carrying shRNA targeting Gpr124. Thus
the cells were divided into a blank control group
a high glucose control group
a high glucose+shRNA group
and a high glucose+Gpr124 shRNA group. Cell scratch test was performed to evaluate cell migration
and Matrigel plug assay was employed to assess the cell tubule formation. Western blotting was applied to detect the protein levels of Gpr124
VEGFA
MMP9
and β-catenin.
Results
2
The HRMEC from the high glucose group showed enhanced cell viability and increased number of proliferating cells compared to the cells of the blank group (
P
<
0.01). High glucose treatment also induced increased expression levels of Gpr124
VEGFA and MMP9 (
P
<
0.01)
and larger migratory area and
in vitro
angiogenic area as well as longer tube diameter at all time points when compared with the conditions in the blank control group (
P
<
0.01). However
knockdown of Gpr124 resulted in a significant decrease in HRMEC migration and
in vitro
angiogenic capacity
accompanied by decreases in protein expression of VEGFA
MMP9 and β-catenin (
P
<
0.01).
Conclusion
2
Gpr124 can regulate the proliferation
migration
and tube formation ability of HRMEC under high-glucose condition
and also inhibit the overexpression of VEGFA and MMP9
which may be through regulating the classical Wnt/β-catenin pathway.
ANTONETTI D A, SILVA P S, STITT A W. Current understanding of the molecular and cellular pathology of diabetic retinopathy[J]. Nat Rev Endocrinol, 2021, 17(4): 195-206. DOI: 10.1038/s41574-020-00451-4.
TEO Z L, THAM Y C, YU M, et al . Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J ] . Ophthalmology, 2021, 128(11): 1580-1591. DOI: 10.1016/j.ophtha.2021.04.027.
YANG J, LIU Z S. Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy[J]. Front Endocrinol, 2022, 13: 816400. DOI: 10.3389/fendo.2022.816400.
GONZALEZ-CORTES J H, MARTINEZ-PACHECO V A, GONZALEZ-CANTU J E, et al . Current treatments and innovations in diabetic retinopathy and diabetic macular edema[J ] . Pharmaceutics, 2022, 15(1): 122. DOI: 10.3390/pharmaceutics15010122.
KARAMAN S, LEPPÄNEN V M, ALITALO K. Vascular endothelial growth factor signaling in development and disease[J]. Development, 2018, 145(14): dev151019. DOI: 10.1242/dev.151019.
VALLON M, ROHDE F, JANSSEN K P, et al . Tumor endothelial marker 5 expression in endothelial cells during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of cell proliferation[J ] . Exp Cell Res, 2010, 316(3): 412-421. DOI: 10.1016/j.yexcr.2009.10.013.
WANG Y, CHO S G, WU X, et al . G-protein coupled receptor 124 (GPR124) in endothelial cells regulates vascular endothelial growth factor (VEGF)-induced tumor angiogenesis[J ] . Curr Mol Med, 2014, 14(4): 543-554. DOI: 10.2174/1566524014666140414205943.
CHANG J L, MANCUSO M R, MAIER C, et al . Gpr124 is essential for blood-brain barrier integrity in central nervous system disease[J ] . Nat Med, 2017, 23(4): 450-460. DOI: 10.1038/nm.4309.
ZHOU Y L, NATHANS J. Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical Wnt signaling[J]. Dev Cell, 2014, 31(2): 248-256. DOI: 10.1016/j.devcel.2014.08.018.
LAN J, YANG M, CHEN X, et al . Haem relieves hyperoxia-mediated inhibition of HMEC-1 cell proliferation, migration and angiogenesis by inhibiting BACH1 expression[J ] . BMC Ophthalmol, 2021, 21(1): 104. DOI: 10.1186/s12886-021-01866-x.
TIAN R, LIU Z X, ZHANG H, et al . Investigation of the regulation of round about4 by hypoxia-inducible factor-1α in microvascular endothelial cells[J ] . Invest Ophthalmol Vis Sci, 2015, 56(4): 2586-2594. DOI: 10.1167/iovs.14-14409.
SHARMA N K, GARDINER T A, ARCHER D B. A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats[J]. Am J Ophthalmol, 1985, 100(1): 51-60. DOI: 10.1016/s0002-9394(14)74982-7.
SELVAM S, KUMAR T, FRUTTIGER M. Retinal vasculature development in health and disease[J]. Prog Retin Eye Res, 2018, 63: 1-19. DOI: 10.1016/j.preteyeres.2017.11.001.
EELEN G, DE ZEEUW P, SIMONS M, et al . Endothelial cell metabolism in normal and diseased vasculature[J ] . Circ Res, 2015, 116(7): 1231-1244. DOI: 10.1161/CIRCRESAHA.116.302855.
HOYING J B, UTZINGER U, WEISS J A. Formation of microvascular networks: role of stromal interactions directing angiogenic growth[J]. Microcirculation, 2014, 21(4): 278-289. DOI: 10.1111/micc.12115.
KANG Q Z, YANG C X. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications[J]. Redox Biol, 2020, 37: 101799. DOI: 10.1016/j.redox.2020.101799.
VISHWAKARMA S, KAUR I. Molecular mediators and regulators of retinal angiogenesis[J]. Semin Ophthalmol, 2023, 38(2): 124-133. DOI: 10.1080/08820538.2022.2152706.
SACKS D B, ARNOLD M, BAKRIS G L, et al . Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J ] . Diabetes Care, 2023, 46(10): e151-e199. DOI: 10.2337/dci23-0036.
LIU Y, CHEN J G, LIANG H W, et al . Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK/ERK signaling[J ] . Stem Cell Res Ther, 2022, 13(1): 258. DOI: 10.1186/s13287-022-02927-8.
YAO Y F, SONG Q X, HU C Q, et al . Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes[J ] . Cardiovasc Res, 2022, 118(1): 196-211. DOI: 10 .1093/cvr/cvab013.
LI M N, DENG L, XU G S. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho[J]. Mol Med, 2021, 27(1): 106. DOI: 10.1186/s10020-021-00365-5.
PASSANITI A, KLEINMAN H K, MARTIN G R. Matrigel: history/background, uses, and future applications[J]. J Cell Commun Signal, 2022, 16(4): 621-626. DOI: 10.1007/s12079-021-00643-1.
CAMPOCHIARO P A, AKHLAQ A. Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases[J]. Prog Retin Eye Res, 2021, 83: 100921. DOI: 10.1016/j.preteyeres.2020.100921.
POUW A E, GREINER M A, COUSSA R G, et al . Cell-matrix interactions in the eye: from Cornea to choroid[J ] . Cells, 2021, 10(3): 687. DOI: 10.3390/cells10030687..
HE X, SEMENOV M, TAMAI K, et al . LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way[J ] . Development, 2004, 131(8): 1663-1677. DOI: 10.1242/dev.01117.
CHO C, SMALLWOOD P M, NATHANS J. Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-specific signaling in mammalian CNS angiogenesis and blood-brain barrier regulation[J]. Neuron, 2017, 95(5): 1221-1225. DOI: 10.1016/j.neuron.2017.08.032.
VALLON M, YUKI K, NGUYEN T D, et al . A RECK-WNT7 receptor-ligand interaction enables isoform-specific regulation of Wnt bioavailability[J ] . Cell Rep, 2018, 25(2): 339-349. e9. DOI: 10.1016/j.celrep.2018.09.045.
TA S, RONG X F, GUO Z N, et al . Variants of WNT7A and GPR124 are associated with hemorrhagic transformation following intravenous thrombolysis in ischemic stroke[J ] . CNS Neurosci Ther, 2021, 27(1): 71-81. DOI: 10.1111/cns.13457.
CHEN Y, HU Y, ZHOU T, et al . Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models[J ] . Am J Pathol, 2009, 175(6): 2676-2685. DOI: 10.2353/ajpath.2009.080945.
VISHWAKARMA S, GUPTA R K, JAKATI S, et al . Molecular assessment of epiretinal membrane: activated microglia, oxidative stress and inflammation[J ] . Antioxidants (Basel), 2020, 9(8): 654. DOI: 10.3390/antiox9080654.
0
浏览量
249
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621